NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

When NorthwestBio submitted the Marketing Authorization Application for DCVax-L to the MHRA in December 2022, they weren’t just asking for approval of a novel drug. They were asking the UK regulator to assess and potentially authorize an entirely new category of medicine.

MHRA has already approved an autologous DC vaccine that uses the patient's own cells.,

They have approved other personalized cell therapies.

The idea DC-L is so novel is just a case of disconnect from the real world often exhibited by "certain longs".